Concepedia

Christopher Grantham

CG

3

Publications

259

Citations

3

H-Index

2005

Active since

Affiliations

Johnson & Johnson (United States)(Current)

Christopher Grantham is an author at Johnson & Johnson (United States) specializing in neuroprotection, social sciences, and neurochemistry.

Top concepts

Publications per year

2005–2010

3

Publications

3

Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits

Hugo Geerts, Pierre-Olivier Guillaumat, Christopher Grantham et al. · Brain Research · 2005 · 143 citations

, , +9

Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

Theo Dinklo, Hamdy Shaban, Jan Willem Thuring et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 76 citations

Identifying Modulators of hERG Channel Activity Using the PatchXpress® Planar Patch Clamp

Adrienne E. Dubin, Nadia Nasser, Jutta Rohrbacher et al. · SLAS DISCOVERY · 2005 · 40 citations · Full text

Rows per page

1–3 of 3